Regenerative Medicine Stocks List

Regenerative Medicine Stocks Recent News

Date Stock Title
Apr 24 ABBV AbbVie breaks six day winning cycle, trades in the red
Apr 24 ABBV Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
Apr 24 VTGN Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression
Apr 24 ABBV 4 Large Drug Stocks to Hold on to Amid Industry Challenges
Apr 24 ABBV What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Apr 24 ABBV Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Apr 23 ABBV Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
Apr 23 LSTA Lisata Therapeutics advances lead asset LSTA1 for treatment of advanced solid tumors
Apr 23 ABBV Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Apr 23 ABBV Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Apr 23 ABBV Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
Apr 23 LSTA Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Apr 22 ABBV AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Apr 22 ABBV EU regulators approve Pfizer antibiotic Emblaveo
Apr 22 ABBV Buying the Dip in These 3 Undervalued Dividend Stocks
Apr 21 ABBV Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 19 ABBV The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Apr 19 ABBV Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Apr 19 ABBV Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Apr 19 BLFS Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling
Regenerative Medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.Some of the biomedical approaches within the field of regenerative medicine may involve the use of stem cells. Examples include the injection of stem cells or progenitor cells obtained through directed differentiation (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells (immunomodulation therapy); and transplantation of in vitro grown organs and tissues (tissue engineering).

Browse All Tags